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Abstract
Background
Diabetic retinopathy (DR) can lead to visual impairment and blindness if not detected and
treated in time. Knowing the barriers/enablers in advance in contrasting different country
income settings may accelerate development of a successful DR screening (DRS) program.
This would be especially applicable in the low-income settings with the rising prevalence of DR.
Objectives
The aim of this systematic review is to identify and contrast the barriers/enablers to DRS for
different contexts using both consumers i.e., people with diabetes (PwDM) and provider per-
spectives and system level factors in different country income settings.
Methods
We searched MEDLINE, Embase, CENTRAL in the Cochrane Library from the databases
start date to December 2018. We included the studies reported on barriers and enablers to
access DRS services based at health care facilities. We categorised and synthesized
themes related to the consumers (individuals), providers and the health systems (environ-
ment) as main dimensions according to the constructs of social cognitive theory, supported
by the quantitative measures i.e., odds ratios as reported by each of the study authors.
Main results
We included 77 studies primarily describing the barriers and enablers. Most of the studies
were from high income settings (72.7%, 56/77) and cross sectional in design (76.6%, 59/
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77). From the perspectives of consumers, lack of knowledge, attitude, awareness and moti-
vation were identified as major barriers. The enablers were fear of blindness, proximity of
screening facility, experiences of vision loss and being concerned of eye complications. In
providers’ perspectives, lack of skilled human resources, training programs, infrastructure of
retinal imaging and cost of services were the main barriers. Higher odds of uptake of DRS
services was observed when PwDM were provided health education (odds ratio (OR) 4.3)
and having knowledge on DR (OR range 1.3–19.7).
Conclusion
Knowing the barriers to access DRS is a pre-requisite in development of a successful
screening program. The awareness, knowledge and attitude of the consumers, availability
of skilled human resources and infrastructure emerged as the major barriers to access to
DRS in any income setting.
Introduction
Diabetes mellitus (DM) is one of the most prevalent non-communicable diseases which
imposes a significant impact on health systems. The International Diabetes Federation (IDF)
estimated that there were 425 million people with diabetes (PwDM) in the world in year 2017
and this will increase to 629 million by 2045 [1]. It has been emphasised that efforts should be
made to prevent the complications of DM as per the targets set in St Vincent declaration in
1989 [2]. It was targeted to reduce the blindness due to diabetic retinopathy (DR) by one third,
by raising awareness among the PwDM and by improving the capacity to deliver services by
the providers. DR is a common microvascular complication of the eyes caused by chronic
hyperglycaemia. Blindness due to DR is common among the working age populations and it is
becoming a global issue due to rising prevalence of DM [3]. Though proportion of blindness
due to DR is low compared to other causes of blindness, expenditure related to DR is a burden
to any health system [4].
Penchansky and Thomas described the concept of access as the “degree of fit” between
clients and the health system [5]. Healthcare access for PwDM has an especially significant
role in the prevention of sight loss due to DR. Access to health care remained a vague con-
cept, until recently, impeding the work of health care policy makers. Optimal access to
health care was defined by Rogers et al., (1999) as “providing the right service at the right
time in the right place” [6]. In generic literature it is mentioned that access has multiple
dimensions and it is not merely the entry in to the healthcare system [5]. Further it is an
outcome of people’s potential to use health care and manifestations of patients actual use
[7]. Donabedian has observed that the proof of access is use of service, not simply the pres-
ence of a facility [8]. Some authors argue that it depends on acceptability of the services as
well [9,10]. It is mentioned that inequalities have been observed in detection and treatment
of DR which require multi-sectoral engagement [11]. Further, universal coverage cannot be
achieved without addressing the barriers [12]. One review mentioned that there are many
reasons for underutilization of eyecare and that the risk of blindness varies with the context
[13]. It has been shown that culturally competent care should be delivered in a diverse
patient community overcoming the sociocultural barriers [14,15]. This is especially relevant
with regard to healthcare delivery for DR.
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Screening of DR can be done opportunistically or proactively. Current literature shows that
proper disease control of DM, diabetic retinopathy screening (DRS) and early identification
and treatment of pathologies will reduce progression of sight threatening DR (STDR) [16–20].
Awareness of the need for detecting DR at a symptomless stage is a key factor in uptake and
regular follow up of DRS services [21]. There are many obstacles for implementation and
maintaining satisfactory level of uptake in DRS at a program level. One important approach to
address this issue is identification of barriers and enablers in the system in advance. The barri-
ers to access DRS could vary according to the country income level and various system factors
in each setting. Different economic and socio-cultural factors would affect the access. Knowing
the impeders in each setting will enable successful implantation of DRS strategies. Especially
this will enable to identify effective strategies for low and middle-income settings, as we can
expect a rise in number with DR in future [1]. Defining a barrier will enable implementation
of public health strategies to improve access [5]. The barriers such as lack of knowledge and
awareness on DR by the consumers and lack of training, skills and screening equipment for
the providers would impede the access to DRS. A barrier could lead to a different outcome for
a certain community such as difficulties in mobility for people with disabilities [22]. In system
assessments authors mentioned that economic and logistic reasons hinder the provision of
screening services [23]. Yet, it is mentioned that effective strategies are frequently underuti-
lised in developing countries to overcome such barriers [24]. Therefore, it is necessary to
understand the potential barriers in accessing and challenges in provision of DRS services in
any health system.
The successful uptake of DRS services depends on the personal factors related to the con-
sumer as an agency [25]. These factors may be modifiable or not modifiable according to the
environment. The required behavioural change techniques for a target population could be
hypothesised using various behavioural models. The “social cognitive theory” explains how per-
sons acquire and maintain specific behavioural patterns and it provides the basis of most inter-
vention strategies to overcome a defined barrier [26]. A person’s behaviour influences and is
influenced by personal factors and the social environment (‘Reciprocal determinism’) [27].
This will lead to self-efficacy of the person to achieve confidence for performing a particular
behaviour. We hypothesised that identification of barriers at individual PwDM and provider /
system level as the environment would enable to identify the impeders in advance. Therefore,
assessment of behavioural patterns and perceived barriers in accessing DRS services may be
useful in developing strategies for a successful DRS program in any context.
The current evidence provides information on barriers without considering the settings.
However, barriers to access DRS are different in various country income levels and health sys-
tems. One review described interventions to promote DRS uptake [28]. In addition, there was
another Cochrane review on quality improvement interventions to increase DRS attendance
[29]. Another recently published review has also considered the barriers to access DRS without
specifying the setting [30]. In addition, this review mostly focused on improving the atten-
dance at existing services. In our review we explored the barriers in broader dimensions
including planning and implementation especially in low income settings, without limiting to
attendance. More over most of the available reviews described barriers based on modifiable
themes or factors that would affect DRS uptake. However, we proposed to identify non-modi-
fiable barriers as well, since this knowledge will be useful to identify the defaulters / those who
are at risk of sight loss in advance. In addition, another review has included studies only after
the year 2003 considering the effective implementation of programs following ‘St Vincent Dec-
laration’ [31]. However this review was then limited to the studies only from high income
countries (HIC) since most of the programmes were implemented in European countries [31].
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Most of the available studies had provided the evidence of barriers to access DRS services
according to the presumed typology of barriers. The processes related to DRS uptake can be
considered at three levels i.e., consumer, service provider and eyecare system. Therefore, in
this review we categorised the reported themes or variables under above categories. We specifi-
cally tried to assess the challenges faced by the providers at established healthcare facilities that
have DRS services, in addition to studying barriers for consumers. In broad definitions, barri-
ers to access to DRS are not only limited to the access issues at the point of delivery, but it also
involves all the steps which take place starting from perceptions of a PwDM at one end to the
whole eye care system at the other end which are inter-related and connected to each other.
Objectives
The overall aim of the review was to explore barriers to access DRS in various country income
settings. The review has the following specific objectives.
• To assess the barriers and enablers to uptake of DRS services by PwDM by country income
category.
• To assess the challenges faced by the services providers in provision of DRS services and to
identify the enablers for development of a DRS program in each setting.
The secondary objectives of this review were;
• To assess the socio-demographic and economic factors that could affect DRS uptake.
• To assess the barriers or enablers to develop a DRS program in a health care system.
Methods
We included studies that focused on assessing barriers and enablers to access DRS. In addition,
we found studies that described factors affecting the uptake of DRS services. Following criteria
were used for assessment of eligibility of the studies. (There is no protocol registration for this
review and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
checklist was included as S1 Table).
Inclusion of studies -
• Consumers—The studies which have assessed the barriers at group or individual level of
PwDM at or who had been referred to a permanent health care facility for DRS.
• Service providers—Studies in which participants were service providers who have direct con-
tact with PwDM in a permanent health care institution and / or clinical decision makers /
other stake holders involved in DRS service related decision making.
Exclusion of studies -
• Studies which have obtained the study sample from the general population without specify-
ing the status of DM.
• Absence of standard diagnostic criteria for DM.
• Studies assessing barriers for eye care in general, without specifying DRS.
• Studies assessing barriers for screening DM complications in general, without specifying the
barriers for DRS.
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We did not restrict the studies for inclusion by study design. We included studies that used
qualitative, quantitative and mixed methods.
Type of participants
We included the studies that have covered PwDM who were attending an existing DRS pro-
gram, diabetic medical care or an eye care facility.
Type of interventions
We included studies that delivered or considered DRS primarily at an established health care
facility. We defined the DRS as performance of dilated retinal screening using imaging (digital /
colour films) or by direct / indirect ophthalmoscopy by a trained / skilled eye care professional
(preferably an ophthalmologist / retinologist) to identify the signs of DR.
Type of outcome measures
We defined access as all level of factors affecting the processes of DRS in a health care facility.
Phenomena of interest
We included the studies which have assessed barriers or enablers to access DRS by PwDM and
challenges or incentives faced by providers in provision of screening services in current screen-
ing programs or at opportunistic screening.
Search method for the identification of studies
We searched Ovid MEDLINE, Embase and CENTRAL in the Cochrane Library from the data-
bases inception up to 15th December 2018. The search strategy was developed by an informa-
tion specialist from Cochrane Eyes and Vision (IG) (search terms available in S2 Table). We
did not use any filtering methods to limit the results by study design, year of publication or
language. This yielded a comprehensive coverage of published articles. However due to
resource restrains we were not able to translate any non-English reports.
Data collection and analysis
Two reviewers (PN and SK) independently assessed the eligibility of inclusion by going
through titles and abstracts of 16,388 articles after, importing them to an EndNote library. The
potential articles (full papers as identified by either or both reviewers) were retrieved from
publishers. These papers were then assessed independently by the two reviewers (PN and SK).
Disagreements between the reviewers were resolved by a 3rd arbitrary reviewer (GV). Review-
ers assessed full papers independently to retrieve accurate data. We aimed to include all rele-
vant studies from different income settings to avoid bias in selecting articles. Therefore, we
were able to extract a range of barrier themes with a greater variation and a greater conceptual
diversity.
Data extraction and management
We developed an MS Office Excel data sheet to directly transfer extracted data from full arti-
cles. The topics to be extracted were developed according the “Strengthening the Reporting of
Observational Studies in Epidemiology” (STROBE) statement and modelling has been done
according to the review question [32]. The accuracy of extracted data was cross-checked by a
third reviewer (SH).
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We extracted information on first author’s name, year of publication, country of study (by
income category), place of the study, sample size, gender distribution, mean age, method of
diagnosing DM, level of DM and DR of the participants and method of DRS in the 1st set of
data. In the next step we collected information on type of study design, objective, study setting,
data sources, sampling strategy and time period when study was conducted. The methodologi-
cal quality assessment and applicability for review question were done separately as subse-
quently described. We extracted the results and main outcomes of each study according to the
review question.
In the synthesis of evidence “informants” were authors of the individual studies rather than
the participants. The authors’ interpretations were presented as narrative themes supported by
numerical values of statistical significance levels wherever available.
While authors’ interpretations were primarily collected from the results section of each
paper, sometimes interpretations were also found in the discussion section. These were also
extracted when relevant and if adequately supported by data. Finally, we tabulated the results
by level of income of the country according to the World Bank 2016 classification.
Assessment of risk of bias in included articles
We carried out the risk of bias and quality assessment according to the guidelines of critical
appraisal of skills program (CASP) tools for case-control, qualitative, cohort and randomised
controlled study designs [33] and National Institute of Health, United States quality assess-
ment tool (NIH-QAT) for observational cohort and cross sectional study designs [34]. Two
reviewers (SH and PN) independently applied the set of quality criteria to each included study.
We appraised how well the individual studies which contributed to narrative synthesis, were
conducted using the above tools. Emphasis was given more to the applicability of the study
according to the inclusion criteria. It has been noted that applicability to the review question
was the main concern in the synthesis rather than the overall level of quality of a study (S3
Table).
Assessment of methodological limitations
When several studies with varied methodological limitations contributed to a finding, we
made an overall judgement about the distribution of strengths and weaknesses of the study
rather than for individual components in the tools.
Assessing coherence
We assessed the coherence of each review finding by looking at extent to which we could iden-
tify a clear pattern across the data contributed by each of the individual studies. This was sup-
ported by when clarity of the themes was consistent across different contexts and the
variations were explained by the study authors according to the data collected, when supported
by numerical data (odds ratios). This was further strengthened when findings were drawn
from different settings.
Data synthesis
Most of the eligible studies were observational and descriptive in nature hence narrative
reporting approach was used to generate new insights. We analysed and synthesised the
descriptive and qualitative data narratively supported by other associated variables with levels
of statistical significance. We described the barriers and enablers according to the dimensions
of the typology of barriers and this in turn was tied with processes involved in DRS. We
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followed a content analysis, by developing themes a priori and tabulation and frequency
counting to identify the major themes. We considered consumer, provider and system factors
as the major constructs according to the social cognitive theory. Themes were presented
graphically using harvest plots. When describing the themes, we did not re-phrase the original
findings or conclusions mentioned by authors. We used imputations up to a certain degree in
describing enabler themes.
Considering the participants of the studies, the themes that emerged were divided in to
three categories complying with the objectives of the systematic reviews. These categories were
consumer perspectives, provider perspectives and system factors. We assumed that this type of
decomposition will be helpful to commission to inform strategies for development of a suc-
cessful program and enhance the policy relevance and applications.
Results
Results of the search
Search and study selection procedures are summarized in the PRISMA flow diagram (Fig 1).
The database search identified a total of 16,388 records. Duplicate records were removed, and
we assessed 16,331 titles and abstracts for potential inclusion in the review. We excluded
16,204 records based on the information given in the title and abstract. After assessing the full-
text of 127 reports of studies, we excluded 50 studies which did not meet the inclusion criteria
and included a total of 77 studies in the review.
Overview of the included studies
We identified a total of 16,331 titles and abstracts and considered 127 full text papers for inclu-
sion in this review and data were extracted from 127 full reports. Seventy-seven (77/127,
60.6%) studies were eligible for inclusion in the narrative review according to the objectives.
The S6 Table file contains the details of participants and settings.
Included studies
This analysis mainly comprised of cross-sectional observational studies. In the included 77
studies, there were 59 (59/77, 76.6%) cross sectional observational studies (observational 33,
Fig 1. PRISMA flow chart.
https://doi.org/10.1371/journal.pone.0198979.g001
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retrospective studies 8, postal surveys 1, telephone interview 2, 1 mixed method audit and 14
population-based studies (14/77, 18.1%)). Other study designs were 3 controlled trials (3/77,
3.9%),1 case control study (1/77, 1.3%), 4 cohort studies (4/77, 5.2%) and 8 qualitative studies
(8/77, 10.4%). There were also 2 reviews (2/77, 2.6%) in the included studies.
Methodological quality of the studies
The methodological quality assessments of included studies are presented in S3 Table accord-
ing to the study design. In the included cross-sectional studies, 96% (57/59) of the studies
clearly stated study objective matching the review question. Sample size justification was not
available in 51% (30/59) of the studies. Participation of eligible persons i.e., facility based diag-
nosed PwDM, at least 50% was not seen in seven (7/59, 12%) studies and eight studies (8/59,
13%) did not report on this aspect. Four of the studies (4/59, 7%) had not recruited the partici-
pants from a similar population. The outcome measures were not clearly defined in 14 studies
(14/59, 24%) and confounders were not adjusted in eleven studies (11/59, 19%).
An acceptable method of recruitment of the cohort was not followed in all four of the
included cohort studies. In included randomised controlled study designs, applicability of the
results to the PwDM was not observed in two studies (2/3, 66%). In qualitative study designs,
most of the quality assessment criteria were met except, relationship between researcher and
the participants were not adequately considered in two studies (2/8, 25%) and in one study (1/
8, 12.5%) recruitment strategy was inappropriate; i.e., those who had worse vision (no percep-
tion to light in any eye) had been excluded from the qualitative interviews. There was one
case-control design with appropriate methodology.
Study populations/groups
All the studies main group of respondents were PwDM. Some authors have sought barrier per-
spectives form providers as well. Fifty-four studies (70.1%, 54/77) described barriers related to
consumers, providers and eye care system, 3 studies on consumers and system (3.9%, 3/77), 2
studies on provider and system (2.6%, 2/77) and 12 studies on consumer and provider (15.6%,
12/77). Only 5 studies (6.5%, 5/77) described barriers of consumers only and one study has
focused only on providers (1.3%, 1/77). In these 77 studies, two studies reported the outcome
as a review [35,36].
Study Settings-by income
Only three (4.8%, 3/63) studies were from low income countries (LIC) (Sub-Saharan Africa (as
a review), Tanzania and Nepal) [35,37,38]. Eleven were from lower middle income countries
(LMIC) (14.2%, 11/77) (Indonesia, India, Yemen, Kenya, Myanmar, Nigeria and Bangladesh)
[39–49], seven from upper middle income countries (UMIC) (9.1%, 7/77) (Turkey, Iran, Med-
iterranean countries and China) [50–56] and 56 from HICs (72.7%, 56/77); (17/77–22.1%
from United Kingdom, 20/77–25.9% from United States, Other 40/77–51.9%—Germany,
France, Ireland, Singapore, Canada, Oman, Hong Kong, South Korea, Australia, Taiwan, Italy
and Netherland) [21,57–111].
Setting-by type of institution
Most of the data collections were done under the primary level general practices, local clinics,
rural outreach clinics and primary care clinics (20/77, 25.9%) [44,48,49,59,60,63,66,67,69,
71,85, 89,92,93, 95,102,105,106,109,110]. There were 14 population-based studies (14/77,
18.1%) [45, 54, 55, 61,62, 75,76,79,81,88,90,91,98,100]. Eleven studies were conducted at
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tertiary level institutions (11/77, 14.3% - 8 eye clinics, 1 diabetic clinic, 1 general medical clinic
and 1 endocrinology clinic) [37–39, 41,46,47,50,53,99,111,112]. Seven studies were conducted
in existing DRS programs (7/77, 9.1%) [64,86,87,96,97,103,107]. Nine studies were conducted
at secondary level medical and diabetes clinics (9/77, 12.7%) [43,51,68,70,74,84,104,108,113].
Five studies were conducted by analysing existing data bases (5/77, 6.5%) [72,77,78,80,83].
There was one study where authors did not mention about the setting, however we could
assume it was at an ophthalmologist clinic through an insurance scheme [73] and two studies
reported the barriers as a review [35,36]. Two studies collected the sample of PwDM at a
screening camp and at an annual campaign.[40,101]. One study was conducted in a an ambu-
latory clinic based at a nursing home [57]. Three studies conducted at eye clinics (3/77, 3.9%; 2
at general eye clinic [42,94] and 1 optometry practice [82]. One study conducted using at a
model of not for profit health model [65]. A study exclusively on providers’ perspectives
recruited stakeholders at national level [56].
Synthesis
Our main objective was to identify barriers or enablers to access DRS. Our findings are sum-
marised in the S4 and S5 Tables files according to the country income.
Narrative summary—Barriers
The following main themes were derived from descriptive and qualitative studies (S5 Table).
Low income countries
The most prominent barriers to access DRS among the consumers in LIC were lack of knowl-
edge on DM eye complications, lack of awareness about importance of eye examination and
lack of knowledge about availability of eye clinics. Among providers, main challenges were
lack of skilled human resources and lack of access to DR imaging and treatment infrastructure.
Further, non-existence of a referral system and lack of multi-disciplinary care approach were
barriers to provision of DRS services. In LIC, lack of a national policy and competing disease
priority environments were the main obstacles in the system (S5 Table).
Lower middle-income countries
Consumers’ barriers related to knowledge and awareness could be observed in the LMIC as
well. This was associated with poor general education and low functional health literacy. Most
of the studies found that health beliefs such as no need of screening at asymptomatic stage,
misconceptions on DR and unawareness of the need for regular screening affected the attitude
of uptake of services. In addition, studies with PwDM reported that lack of time and lack of
family support hindered access. Additionally, financial barriers and disabilities emerged as
themes of barriers.
In providers perspectives lack of DM health education and financial constraints were the
main barriers. Lack of human resources, uneven distribution of skilled personnel, lack of avail-
ability of equipment i.e., imaging technology, DRS related consumables such as pupil dilating
drops and treatment facilities were observed as main service provider barriers. Some studies
reported that lack of knowledge and awareness on DR among the physicians, lack of skills in
identifying DR as well. In addition, low referral rates and time constraints in busy eye clinics
were the main challenges faced by providers in LMICs in provision of DRS services. In system
analysis lack of training, lack of accessible eye centres, poor public transportation systems and
lack of epidemiological studies were emerged as main barriers (S5 Table).
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Upper middle-income countries
The lack of awareness and knowledge on DR emerged as the main barrier among the PwDM
in UMIC. This was associated with low literary and poor educational levels in UMIC as well.
Poor physician-patient communication was also a barrier in these countries. In provider per-
spectives scarce human resources, lack of training, high number of PwDM were the main chal-
lenges faced. In addition, poor provider awareness on screening guidelines and lack of
imaging technology hindered provision of services. In the system analysis limitations in pre-
vention and health promotion, poor usage of prevalence data, lack of information systems,
lack of auditing systems, civil unrest, disparity in urban and rural services, lack of transporta-
tion and problems in insurance schemes were the main barriers to accessing DRS services (S5
Table).
High income countries
In HIC living alone, problems in mobility, multiple comorbidities, negative self-perceptions,
problems in accessing general practitioner, effects of mydriasis prohibiting driving, reluctance
to change behaviour, disliking the method of examination, change of residence, problems in
securing appointments, being employed, extended vacations were observed as the main barri-
ers among the consumers. In some HIC, lack of knowledge regarding eye examination, lack of
knowledge on need of screening during asymptomatic stage, misconceptions, lack of aware-
ness of eye care, lack of flexibility in adjusting attitude and behaviour and lack of understand-
ing of rationale and importance of annual eye examination were observed as barriers to access
DRS services. Even in the HIC socio-economic inequalities, poor communication skills, social
deprivation and poorer literacy were barriers to access DRS services among some
communities.
In the providers perspectives; level of experience of the screener, lack of attention by the
general practitioners, non-adherence to guidelines, lack of information provided to patients,
lack of physician recommendations, lack of coordination between general practitioners and
screeners, limited knowledge on DR among the health professionals, long waiting time (large
number of patients per doctor), failure to refer by general practitioner, perceptions of side
effects of mydriasis, limited knowledge-attitude and practice of physicians, limited experience
in using ophthalmoscope, long waiting time for treatment, lack of communication between
screening services and practices were mentioned as barriers. Providers mentioned that prob-
lems associated with consumers such as confused and immobile patients, unawareness of
importance of mydriasis, poor physician-patient communication, different perceptions in
making appointments, after effects of mydriasis, fear of laser, and wrong assumption on
patient’s level of knowledge could hinder to access DRS services.
In HIC system analysis lack of understanding among the specialities, frequent change of
staff, lack of human resources, unavailability of medical records, lack of adequately trained
optometrists, lack of proper referral and reminding system, lack of insurance coverage, finan-
cial barriers, unavailability of national programs, problems in transportation and lack of
screening programs in remote areas were barriers to access or provision of DRS. The studies
reported that among system factors, integration of screening to the general health systems,
governance, quality and safety should be considered in conducting screening programs. (S5
Table).
Overall barriers themes using harvest plots
Considering the number of times a theme appeared irrespective of the country income level;
lack of knowledge (19/77 studies, 25%), lack of awareness (15/77, 20%), low educational
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attainment and poor literacy (16/77, 21%), asymptomatic nature of DR (16/77, 21%), financial
barriers (31/77, 40%) and time and priority issues (12/77, 16%) emerged as the major themes
at consumer level. Similarly, at the provider level accessibility issues related with appointments
(23/77, 30%), lack of human resources (10/77, 13%), lack of knowledge and awareness among
the providers (11/77, 14%), lack of screening infrastructure (11/77, 14%), cost of services (11/
77, 14%) and deficiencies in educating the users (21/77, 27%) reported as major barriers (Figs
2 and 3).
Narrative summary—Enablers
Themes of enablers are summarised in the S5 Table files according to the country income
category.
Low income countries
In LIC settings consumers’ knowledge on DR, having a family member with DM and prior
fundus examination were enablers to attend DRS. Provision of imaging and treatment infra-
structure, increased human resources, provision of training on retinal care and prioritisation
of development of subspecialties were mentioned as enablers for the providers (S5 Table).
Lower middle-income countries
The enablers for uptake of services by the consumers were presence of symptoms, more severe
DM and comorbidities, better understanding of risk factors and detrimental effects, patient
satisfaction over the modality of screening and presence of visual impairment / blindness.
Training of non-ophthalmologist physicians on DRS, availability of fundus camera, educa-
tional strategies aimed at both patients and physicians, reminders of the serious consequences
of failure to undergo DRS, availability of written communication when referring for screening
and public health education using media were emerged as enablers to improve uptake of DRS
services in LMIC. (S5 Table).
Upper middle-income countries
Higher literacy, person’s concern about the vision loss, severe DR stage and having knowledge
on DR were the main enablers for users of DRS services uptake. In UMIC awareness among
the physicians DM complications, availability of referral guidelines, availability of continuous
medical education programs, training of human resources, involvement of community groups
and community-based health education were enablers to improve DRS services by provider
side (S5 Table).
High income countries
The main enablers for screening uptake in HICs were awareness of eye care and possibility of
treating DR, positive reinforcement through negative screening results, worrying about vision
loss, attending DM education classes, discussion of DM complications with health care profes-
sionals, trust on provider, having health insurance with eye care services coverage, higher level
of education and being obliged to attend for screening. Adherence to the best practice guide-
lines by the consumers and having eyes examined by primary care physicians were enablers.
In HIC availability of educational interventions, DM education programs, adherence to
guidelines, targeted screening of high-risk groups, reinforcing the importance of eye examina-
tion by health care providers, constant screening location, personalised strategies on follow up
(phone calls and door to door visits), on-line patient access booking system, recall system,
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showing fundus photograph and teaching patients, ability to change appointments were incen-
tives for uptake of DRS services. The studies conducted in remote areas reported that mobile
tele-screening models it-self was an enabler to improve access (S5 Table).
Overall enabler themes using harvest plots
Considering the number of times, a theme appeared irrespective of the country income level;
presence of symptoms (15/77, 19%), presence of DR or other eye diseases (15/77, 19%), higher
level of education (12/77, 15%), better attitude (12/77, 15%) and high income (10/77, 13%)
were the main enablers for the PwDM. In providers perspective having health education on
regular eye examination (46/77, 60%) and factors convenient for the users (31/77, 40%) were
main enablers (Figs 4 and 5).
Quantitative data synthesis
The data extracted for quantitative synthesis are available as supporting information S5 Table file.
Knowledge and awareness
The main barriers identified in this systemic review were factors associated with consumers.
The most consistent barrier across most of the studies was knowledge regarding DR. One
Fig 2. Harvest plot showing user barriers.
https://doi.org/10.1371/journal.pone.0198979.g002
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study mentioned that knowledge (mean knowledge score 4.7 among those who had examina-
tion vs 3.6 without examination (p<0.001) and awareness about DR was associated with seek-
ing screening services (odds ratio (OR) 1.52, 95%CI 1.1–2.1, p = 0.01) [39]. This concept was
further emphasised in a randomised controlled trial conducted to evaluate the effectiveness of
a health educational intervention, where the intervention arm participants had higher odds of
eye examination status (OR 4.3, 95% CI 2.4–7.8) [68]. A study from China showed that having
a higher DR knowledge score was a potential predictor for ever had an eye examination. (OR
1.31, 95% CI 1.1–1.5, P<0.001) [53]. Similarly, a study conducted in Bangladesh reported that
awareness of DM (OR 8.47, 95% CI 3.95–18.18) and DR (OR 5.15, 95% CI 1.89–14.01) were
associated with improved uptake of DRS services [48].
In a study conducted to enhance the compliance with DRS recommendations, it was seen
that when PwDM were given educational material and a notification there was a significant
difference in screening uptake (OR 1.4, McNemars X2 = 102.7; P< 0.0001) [114]. A study con-
ducted in Tanzania showed that those who had knowledge on damages to eye due to DM had
higher odds of undergoing dilated fundus examination in the past year (OR 19.7, 95% CI 7.0–
55.2) [38].
Fig 3. Harvest plot showing user incentives.
https://doi.org/10.1371/journal.pone.0198979.g003
Systematic review on barriers to DRS
PLOS ONE | https://doi.org/10.1371/journal.pone.0198979 April 23, 2019 13 / 29
Even the knowledge on DM alone was associated with uptake of DRS. A study mentioned
that less practical knowledge about DM (OR 1.5, 95% CI 1.2–2.1) was a factor associated with
non-adherence [88]. A similar finding was reported in the study conducted by Srinivas et al.,
(2017) in India, which shows good knowledge of DM was associated with good practice of DR
(OR 3.95, 95% CI 1.97–7.94 p<0.01) [41]. On the other hand another study mentioned that
knowledge on effects of DR on vision was an incentive for uptake of DRS (OR 3.3, 95% CI 2.0–
5.5) [93]. It was seen that awareness on possibility of treating DR was an incentive for attend-
ing screening (OR 1.6, 95% CI 0.9–3.0) [93]. In contrast, a study conducted in Nigeria showed
that associations between knowledge, attitude and practice and authors concluded that there
was no significant correlation between knowledge and practice (correlation coefficient
r = 0.086, p = 0.385) [47].
Factors associated with awareness
Most of these studies had analysed the various patient characteristics and disease factors asso-
ciated with awareness. Lack of awareness was associated with older age (OR 10.4, p = 0.03),
poorly controlled HbA1c (OR 4.9, p<0.001) and male gender (OR 1.2, 95% CI 0.7–1.8,
p = 0.47) [61]. Huang et al., (2013) showed that unawareness was associated with lower educa-
tion (primary or less, adjusted OR 1.9, 95% CI 1.4–2.5, p<0.0001), lower income (Singapore $
<2000, adjusted OR 1.7, 95% CI 1.2–2.5, p = 0.003) and poorer literacy (unable to write—
Fig 4. Harvest plot showing provider barriers.
https://doi.org/10.1371/journal.pone.0198979.g004
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adjusted OR 1.4, 95% CI 1.0–2.0, p = 0.03) [115]. Katibeh et al., (2017) also showed that a good
level of awareness on DR was associated with secondary or higher education (OR 1.88, 95% CI
1.23–2.88, p = 0.004) [55]. Thapa et al., (2012) mentioned that literate patients are more likely
to have awareness on DR (OR 2.7, 95% CI 1.3–5.6, p = 0.006) [37]. One study showed that
higher awareness on DR was seen among the more educated people (OR 1.8, 95% CI 0. 9–3.4,
p = 0.0000) [54]. Those who have a history of prior fundus evaluation elsewhere (other than
retinal clinics in this study) had higher odds of having awareness on DR (OR 11.9, 95% CI 5.7–
25.2) p<0.001) [37].
Attitude
It was also reported that PwDM themselves may not have the judgemental ability over seeking
care and recommendation by the provider would improve access (OR 341, 95%CI 164–715,
proportion of attendees 99.4% vs non-attendees 34.5%) [93]. In health seeking behaviour,
Fig 5. Harvest plot showing provider incentives.
https://doi.org/10.1371/journal.pone.0198979.g005
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those who thought eye examinations were needed every 6 months (OR 1.2, 95% CI 1.1–1.4)
and those who worry much regarding their vision (following telephone call intervention, OR
3.47, 95% CI 1.8–6.8) showed higher odds of DRS uptake [108,116]. A study showed that per-
ception of a PwDM should have eye examination every 12 months (OR 2.62, 95% CI 1.7–4.1,
p<0.0001) was associated with previous dilated eye examination [71]. Another study showed
that fear among patients on impaired vision was an incentive for DRS (OR 1.9, 95% CI 1.5–
2.5) [93]. Lian et al., (2018) reported that those who worry more about vision loss were highly
likely to attend screening (OR = 1.72, 95% CI 1.31–22.26, p<0.001) [105].
Secondary outcomes of quantitative data—Factors associated with
uptake of screening / adherence / regular follow up
Service user costs
One major factor associated with undergoing DRS was having an insurance scheme. This was
observed mainly in the paid systems, when services are delivered at a user fee and health ser-
vices were not available free of charge. Having an insurance coverage either national or private,
depending on the context, was associated with compliance for annual eye examination
(National health insurance, OR 2.2, 95% CI 1.2–4.3 p = 0.02) [89], increased eye screening
(private health insurance, OR 3.2, 95% CI 2.2–4.7, p = 0.00)[62] and higher chance of undergo-
ing screening (health insurance—type not specified, adjusted OR 1.7, 95% CI 1.4–2.2)[78]. It is
shown that those who have vision loss (blindness) are 100% willing to pay for the services
(mean amount willing to pay-No DR—Taiwan dollars (NTD) 468.9 ± 327.7 vs Blindness NTD
822.2 ± 192.2, p = 0.0005) [91].
One randomised controlled trial showed that PwDM are less likely to undergo DRS when a
co-payment is applied compared to the free services (OR 0.6, 95% CI 0.5–0.7) [67]. Those who
had no health insurance (OR 2.5, 95% CI 1.7–3.7) were less likely to be compliant with screen-
ing [81]. Sheppler et al., (2014) mentioned that those who had an insurance coverage complied
more with annual eye examination (OR 2.2, 95% CI 1.1–4.3, p = 0.02) [89]. Lian et al., (2013)
showed that being in the pay groups was negatively associated with uptake of screening (OR
0.6, 95% CI 0.5–0.7) following random allocation of PwDM to screen for DR at a user fee (US
$ 8) or for free [67]. The study done by Moss et al., (1995) showed that having a health insur-
ance with eye examination covered (OR 3.3, 95% CI 2.2–5.1, p<0.0001) was associated with
previous dilated eye examination [71].
Family income
Two studies found that a higher family income was associated with having had a dilated eye
examination (US $>50,000 vs US $<40,000, OR 1.9, 95% CI 1.3–2.9 [90] and US $>35,000,
OR 1.3, 95%CI 0.8–2.2) [98]. The study done by Paskin-Hall et al., (2013) showed that those
who have a higher income ($35,000-$49,000 adjusted OR 1.3, 95% CI 1.1–1.5) had higher odds
of undergoing DRS [78]. Another study done in South Korea by Rim et al., (2013) showed that
those who were in the highest monthly income quintile (OR 1.4, 95% CI 1.1–1.8, p<0.01) had
higher odds of undergoing screening [83].
Gender
The odds of having had a dilated fundoscopy in the past year was high among women (OR 1.2,
95% CI 0.9–1.5) [90] and past eye care use decreased by being male (OR 0.5, 95% CI 0.3–0.8,
p<0.01) [79]. However a study done in UK showed males had higher odds of attending
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screening following invitation (OR 1.4, 95% CI 1.1–1.7) [111]. Therefore, role of gender with
regard to uptake of DRS could be context specific.
Age
The PwDM > 70 years of age showed higher odds of having undergone dilated fundoscopy
compared with those<40 years of age (OR 1.9, 95% CI 1.5–2.6) [90]. Most of the studies
showed that older PwDM had higher odds of undergoing screening (age >65 years, OR 2.6,
95% CI 1.6–4.1)[98], (OR 1.02, p<0.001) [72].
It was observed that eye care services utilization with in a 12 month period, was lower in
those who are younger (age 20–39 years, OR 0.1, 95% CI 0.01–0.70 p<0.05) [79]. Similarly, a
study done in UK showed that younger age was associated with non-attendance (18–34 years,
adjusted OR 1.4, 95% CI 1.1–1.7, 35–44 years, OR 1.4, 95% CI 1.2–1.7) [111].
Level of education
Most of the studies mentioned the association between level of education and DRS uptake. For
PwDM having more than high school education vs less than ninth grade education (OR 1.5,
95% CI 1.0–2.1) was associated with higher likelihood of having a dilated eye examination
[90]. The reasons for non-adherence mentioned in another study was education less than high
school (OR 1.5, 95% CI 1.1–2.1) [81]. It was observed that the odds of past eye care use
dropped with the decrease in number of years of educational attainment (<10 years, OR 0.4,
95% CI 0.2–0.9, p<0.05) [79].
In addition, education up to high school or more was a predictor of knowledge that uncon-
trolled diabetes could cause eye disease (OR 2.4, 95%CI 1.5–4.0, P<0.05) [73]. Xiong et al.,
(2015) also showed that higher awareness of DR was seen among the more educated people
(OR 1.8, 95% CI 0. 98–3.44, p = 0.0000) [54]. Islam et al., (2018) reported that having second-
ary or higher education was associated with improved DRS uptake (OR 11.8 (95% CI 4.02–
34.7) [48].
Disease factors associated with uptake of screening
Higher level of glycosylated haemoglobin was associated with non-compliance with screening
(>9%, OR 1.7, 95% CI 1.1–2.6) [81].
Diabetes / Eye care education
One study mentioned that those without DM education (OR 0.4, 95%CI 0.2–0.6) are less likely
to undergo screening [50]. Hwang et al., (2015) in Canada showed that increased eye screening
was associated with health professional discussing DM complications with PwDM (OR 2.0,
95% CI 1.3–3.2, p = 0.00) [62]. Persons having attended a DM education class (OR 1.5, 95% CI
1.2–1.9) had higher likelihood of having a dilated eye examination [90].
A study done in USA showed that eye care education (OR 1.6, 95% CI 1.2–2.1) was associ-
ated with receipt of dilated eye examination [98]. No formal DM education (OR 1.3, 95% CI
1.1–1.6) and less practical knowledge on DM (OR 1.6, 95% CI 1.2–2.1) were associated with
non-adherence [88]. Those who had attended a DM education class had higher odds of having
a dilated eye examination in the past year (OR 1.5, 95% CI 1.2–1.9) [90]. It is shown that when
there has not been any education on DM, patients are less likely to visit an ophthalmologist on
a regular basis (OR 0.39, 95% CI 0.24–0.65) [50].
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Personnel who conducted the last eye examination
The described reasons for non-adherence to DRS included, the type of personnel that con-
ducted the last eye examination. It is shown that non-adherence was high when last examina-
tion had been conducted by non-ophthalmologist personnel (OR 4.3, 95% CI 2.3–6.2) [88].
Duration of diabetes
The duration of DM was a predictor of having DR. Those who have had DM for a shorter
duration (<5 years, OR 0.04, 95% CI 0.01–0.10) were less likely to be having DR [42]. One
study mentioned that PwDM who were<5 years (OR 0.4, 95% CI 0.3–0.8) of duration after
diagnosis are less likely to undergo screening [50].
Hwang et al., (2015) in Canada showed that duration of DM longer than 10 years (OR 1.5,
95% CI 1.04–2.25, p = 0.03)] was associated with increased eye screening [62]. Similarly Saa-
dine et al., (2008) mentioned that when the DM duration was longer (>15 years, OR 1.9, 95%
CI 1.4–2.6, p<0.0001) those PwDM were more likely to attend follow ups [84].
A factor positively correlating with eye care use was, time since diagnosis of DM (20 years,
OR 2.7, 95% CI 1.2–5.9, p = 0.041) [79]. In contrast to other studies one research showed that
when the duration of DM goes up, the likelihood of not attending screening also increases (5
to 9 years, OR 1.9, 95% CI 1.6–2.2), (>20 years, OR 3.4, 95% CI 2.7–4.2) [111].
Type of diabetes treatment
Eye care use by PwDM was higher when the treatment is with oral antidiabetics and insulin
(OR 2.8, 95% CI 1.1–7.4, p = 0.161) [79].
Regularity of clinic visits
It was observed that the odds of using eye care in the past year decreased with those who are in
the younger age categories (age 20–39 years, OR 0.09, 95% CI 0.01–0.70, p<0.05), and having
lesser number of years in educational attainment (<10 years, OR 0.37, 95% CI 0.16–0.88,
p<0.05) [79]. Further noncompliance was associated with those who had no routine physical
examination > 1 year ago (OR 1.8, 95% CI 1.3–2.5) [81].
Mukamel et al., (2016) showed that patients who visit their primary care physicians more
often (OR 1.3, 0.001<p<0.01) had higher probability of attending screening in the past 12
month period [72].
Marital status
It was observed that past eye care use as being lower in those who were never married (OR
0.14, 95% CI 0.03–0.76, p<0.05) [79].
Unemployment
Unemployment was inversely associated with eye care use (OR 0.5, 95% CI 0.2–1.1, p = 0.091)
[79].
Alcohol intake
Heavy alcohol consumption was inversely associated with eye care use (OR 0.3, 95% CI 0.1–
0.7, p = 0.003) [79].
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Having other complications of diabetes
Factors inversely associated with eye care use was having diabetic foot disease (OR 0.4, 95% CI
0.2–0.9, p = 0.35) [79]. In contrast a study conducted by Bennet et al., (2018) found that having
non-ocular complications of DM increased DRS attendance (OR 2.7, 95% CI 1.1 to 6.4) [99].
Physician recommendation
Physician recommendation is a predictor of having regular eye examinations as mentioned in
one study done in Ireland (OR 1.3, 95% CI 1.1–1.6) [108]. Van-EijK et al., (2011) showed that
recommendation by the care provider was a strong incentive for undergoing DRS (OR 341,
95% CI 164–715) [93]. A similar association has been mentioned by the Wang et al., (2010)
(OR 2.2, 95% CI 1.5–3.3, P<0.001) [53]. Being referred for eye examination was a strong pre-
dictor of high uptake in a study conducted in Kenya (OR 20.5, 95% CI 10.2–40.9, p< 0.001)
[49].
Having other eye diseases and visual impairment
Those who have other eye diseases (OR 1.2, 95% CI 1.1–1.6) and those who think that eye
examinations are needed every 6 months (OR 1.2, 95% CI 1.1–1.4) showed higher odds of
DRS uptake [108]. Study by Moss et al., (1995) showed that history of cataract (OR 2.9, 95%CI
1.9–4.4, p<0.0001) was associated with previous dilated eye examination [71]. Hwang et al.,
(2015) in Canada showed that increased eye screening was associated with having visual
impairment (OR 2.6, 95% CI 1.7–3.9, p = 0.00) [62].
Social deprivation
Even in HIC people living in deprived areas failed to attend DRS (OR 2.3, 95% CI 1.9–2.8)
[66]. One study stated that people living in most deprived areas (OR 1.2, 95% CI 1.2–1.3) were
more likely to not adhere with screening recommendations [77]. A study done in UK showed
the factors associated with non-attendance following an invitation for screening in a sample of
31,484 diabetics in a DRS program. In this study social deprivation (adjusted OR 1.4, 95% CI
1.2–1.6, p<0.001) was associated with non-attendance [111].
Another study done in South Korea by Rim et al., (2013) showed that those who lived in
urban areas (OR 1.5, 95% 1.2–1.8, p<0.01) and those in the highest monthly income quintile
(OR 1.4, 95% CI 1.1–1.8, p<0.01) had higher odds of undergoing screening [83]. Scanlon
et al., (2008) mentioned that with each increasing quintile of socioeconomic deprivation the
probability of having been screened for DR decreased (OR 1.1, 95%CI 1.1–1.2, P<0.001) [85].
Risk of development of DR among non-attendees
The relative risk of having DR was higher in non-attendees for screening, as shown in one
study conducted in Yemen (Relative risk of having DR 1.5, 95% CI 1.2–2.2), (bilateral blind-
ness 4.0, 95% CI 1.4–11.6) (low vision disability 2.4, 95% CI 1.8–3.5)[42].
Saadine et al., (2008) mentioned that those who have moderate or worse retinopathy (OR
2.2, 95%CI 1.6–2.9, p<0.0001) were more likely to attend follow ups [84].
Discussion
We assessed the barriers and enablers to access and provision of DRS services in various coun-
try level income settings. This is the first systematic review to explore consumer, provider and
health system barriers / enablers, and to understand these in the context of country income
level. Knowing the barriers / enablers by country income setting is useful to identify and
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streamline interventions for the impeders in advance. Though the potential benefits to PwDM
are widely known, attendance is at a sub-optimal level in DRS programs even in HIC settings
[117]. DRS has been shown to be cost effective in terms of sight years preserved [118]. In most
parts of the world DRS remains non-systematic. The findings from this narrative review will
be useful to emphasise the barriers faced by consumers and providers in a DRS program. This
will be helpful to explore the avenues for successful implementation of a DRS program in a
country and how to conduct a program conveniently for both users and providers. We
assumed that identification of secondary factors associated with uptake will be useful in effi-
ciently continuing the programs and to identify the risk groups in advance.
We identified that knowledge and awareness among PwDM as the main barrier to access in
all income settings. A recent review has also emphasised that lack of knowledge and awareness
among PwDM as a major barrier to improve uptake [30]. Under the knowledge theme we
identified many subthemes that would be useful for development of health educational inter-
ventions. Few such sub-themes are asymptomatic nature of DR and knowledge on frequency
of DRS. This aspect has been described in a recent review as behavioural economics to improve
access [119]. Therefore, we could assume that health educational interventions may improve
uptake of services. However, the uptake of DRS services can be affected by various socio-eco-
nomic factors as well, as observed in the review outcomes.
In our review, we identified that in the HIC most of the barriers to access were related to
processes of DRS while in LIC and LMIC they were related to major system factors such as
unavailability of services, lack of human resources and infrastructure. Most of the HIC settings
provide population-based DRS using digital retinal imaging. Therefore, the barriers / enablers
of HICs described in our review were attuned to the processes of DRS using imaging. How-
ever, most of the low-income settings still do not have systematic DRS and it is done as an
opportunistic intervention only. Moreover, mode of DRS in low income settings were based
on bio-microscopy / ophthalmoscopy. At the provider level in LIC and LMIC settings, lack of
skilled human resources and lack of DRS infrastructure were the main barriers, while in
UMIC and HIC it was lack of training and poor coordination between physicians / general
practitioners and screeners. In addition, the LIC and LMIC ophthalmologists are overbur-
dened with most prevalent blinding conditions such as cataract. This reflected in most of the
studies as a barrier, stating the lack of and maldistribution of ophthalmologists. On the other
hand, it has led to increased waiting time for PwDM, which hindered uptake of services.
Synthesis of existing evidence helped to narrow down barriers to identify modifiable
themes. In general, knowledge appeared as the main modifiable barrier to access, from the
user side. However, in a paid healthcare system, low income and financial constrains had been
mentioned frequently. We identified financial barriers as a recurrent theme in the harvest
plots. In addition, most frequently mentioned (i.e., frequency of studies with the theme) bar-
rier by consumers was asymptomatic nature of DR as shown in harvest plot in Fig 2. Therefore,
the need to undergo regular screening even without visual symptoms should be an aspect that
should be emphasised. Complementary to these outcomes, the most common incentives men-
tioned in included studies were better knowledge on DR / DRS, higher level of education, pres-
ence of symptoms and higher level of income as shown in Fig 3. When considering the most
frequently cited barriers by providers, deficiencies in educating users on DR / DRS, issues in
accessibility when making appointments, and long waiting time at eye clinics emerged as the
main barriers (Fig 4). The main enablers for providers were educating users on regular eye
examination and providing better access for PwDM (Fig 5).
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Strengths and limitations
This review included 77 articles from diverse settings. We used a comprehensive approach to
capture all possible articles on this review question. Inclusion of studies without restricting the
study design allowed us to derive a wide range of themes. We used narrative synthesis of data
due to high heterogeneity among the studies. Further we attempted to provide wide range of
barrier and enabler themes by all income settings, incorporating both qualitative and descrip-
tive quantitative studies, without restricting to any study design or income setting.
In order to maintain the homogeneity among the included studies, we divided the studies
according to the income setting. Further we explored whether there were differences in barri-
ers and enablers between different income settings.
A majority of the studies were focused on the perspectives of the users when describing the
barriers. Almost none of the studies explored the perspectives of the policy makers or program
planners. Therefore, this review lacks several aspects of stakeholder perspectives.
We did not look at the community level programs which may take place outside of a medi-
cal or eye care centre. We did not specifically assess the reach or availability of DRS programs,
which could be an important component in access.
The included studies reflected the barriers in a cross section of time. All the studies used
diagnosed PwDM at institutional level as their study samples. There were no studies that used
long term sociological and ethnographic approaches to study barriers to access in their natural
environment over time.
Many of the barriers or enablers identified in this review were peculiar to modality of screening
in the local context. We used a reductionistic approach in this narrative synthesis without further
synthesis of new themes. Another aspect is that the barriers or enablers were assessed in different
health systems which may have different socio-cultural and economic back grounds. Therefore,
we could not assess the interactions between each of the themes we derived. Though we simplified
and de-contextualised the barriers themes, generalizability may depend on the context.
One of the limitations of this review is lack of eligible randomised controlled trials on the
review question and primary outcomes were described as explained by the authors. Consider-
ing the paucity of systematic reviews under this topic, we found it is difficult to compare and
comment in contrast on our findings.
Implications and public health significance of the findings
The narrative synthesis by country income level supported by quantitative data would be help-
ful to identify potential strategies to overcome barriers in each setting. We observed that most
important factor to define barriers is the setting. Therefore, we recommend carrying out an
assessment of barriers and enablers in each context before making recommendations for a
DRS program.
Diabetic retinopathy screening program implementation involves a high capital expendi-
ture. There will be a high level of financial risk when implementing a program for the first
time. By knowing the potential barriers, the risks can be minimised, and access can be
improved by implementing interventions to overcome potential barriers.
The outcomes of the current review will be useful to identify the modifiable barriers which
could be further explored in a local context before implementing costly DRS programs and
interventions. Assessment of user and provider perspectives together enables the identification
and subsequent catering to needs from the demand side as well as the supply side of DRS.
The results of this review show that there are modifiable barriers such as lack of knowledge
on DRS among the PwDM which could be addressed in the development of health promo-
tional strategies.
Systematic review on barriers to DRS
PLOS ONE | https://doi.org/10.1371/journal.pone.0198979 April 23, 2019 21 / 29
This review highlights the gaps in evidence on this topic in LIC and LMIC. Further there
was limited evidence on system factors and perspectives of stakeholders.
Conclusion
The evidence in this review clearly suggests that the barriers and enablers are different in each
income setting. The most consistent barrier across different income settings was lack of knowl-
edge and awareness on DR and DRS among the users. In providers point of view, lack of
skilled human resources and screening infrastructure was the main barrier. Knowing the mod-
ifiable barriers in a specific context would be helpful to identify the risk groups early and to
improve DRS uptake among institutional PwDM. A main recommendation of this review is to
carry out an assessment of barriers and enablers in each context before implementing a DRS
program. The consumer-based health educational interventions and provider-based skills and
DRS infrastructure development would improve the access to DRS especially in low income
settings.
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